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SYNOPSIS: The 6-years follow-up outcomes at far, intermediate and near distances 
confirm that presbyopic treatment using a hybrid bi-aspheric micro-monovision ablation 
profile is safe and efficacious. To increase satisfaction retreatments and reversal 





BACKGROUND/AIMS: To evaluate vision 6-years after hybrid bi-aspheric multifocal 
central presbyLASIK treatments. 
 
Methods: Thirty-eight eyes of 19 patients consecutively treated with central 
presbyLASIK were assessed. The mean age of the patients was 51±3 years at the time 
of treatment with a mean spherical equivalent refraction of -0.57±1.98D and mean 
astigmatism of 0.58±0.57D. Monocular corrected distance visual acuity (CDVA), 
corrected near visual acuity (CNVA) and distance corrected near visual acuity (DCNVA) 
of non-dominant eyes; binocular uncorrected distance visual acuity (UDVA), 
uncorrected intermediate visual acuity (UIVA), distance corrected intermediate visual 
acuity (DCIVA) and uncorrected near visual acuity (UNVA) were assessed pre- and 
post-operatively. Subjective quality of vision and near vision was assessed using the 
10-item, Rasch-scaled, Quality of Vision (QoV) and Near Activity Visual Questionnaires 
(NAVQ) respectively. 
  
RESULTS: At six years post-operatively, mean binocular UDVA was 20/18±4; mean 
binocular UNVA and UIVA were 0.11±0.13logRAD and -0.08±0.08logRAD, respectively.  
Spherical equivalent showed a slow hyperopic drift of +0.1D per year with refractive 
astigmatism stable from 6 weeks postoperatively.  Defocus curves show an 
improvement of 0.4 Snellen lines at best focus from year 1 to year 6 follow-up, reaching 
preoperative levels.  Compared to the preoperative status, the corneal and ocular 
spherical aberrations (at a 6 mm diameter) decreased and were stable from 3 months 
follow-up.  Questionnaires revealed a postoperative unaided QoV Score comparable to 
the preoperative corrected QoV Score, together with an improved postoperative 
unaided NAVQ Score compared to preoperatively. 
  
CONCLUSIONS: Presbyopic treatment using a hybrid bi-aspheric micro-monovision 
ablation profile is safe and efficacious even after 6-years postoperatively. The post-
operative outcomes indicate improvements in binocular vision at far, intermediate and 
near distances. An 8% retreatment rate should be considered to increase satisfaction 






Presbyopia occurs when the physiological age-related reduction in the eyes focusing 
range reaches a point, when optimally corrected for distance vision, that the clarity of 
vision at near is insufficient to satisfy an individual’s requirements.1  
The etiology of the condition is predominantly attributed to a loss of elasticity of the 
crystalline lens, accompanied by a change in the ciliary muscle strength and lens 
curvature.2 Corneal inlays and intraocular lenses have been used as a treatment for 
presbyopia.3 Monovision techniques4 usually involve correcting the dominant eye for 
distance as opposed to crossed monovision5 where the dominant eye is corrected for 
near vision. 
Multifocal ablations are designed to achieve a pseudo-accommodative cornea in 
the form of either a peripheral near zone (concentric ring for near vision)6 or a central 
near zone (central disc for near vision).7 PresbyLASIK is one such technique based on 
traditional laser-assisted in situ keratomileusis (LASIK) to correct the visual defect for 
distance while simultaneously reducing the near spectacle dependency in patients with 
presbyopia.8 PresbyLASIK  is considered a promising technology, but is less 
established when compared to traditional monovision strategies.9 The goal of 
presbyopia refractive surgery is to provide patients with improved near vision without 
decreasing their distance vision. Previous approaches have failed for at least one of 
three reasons: the improvement in near vision was insufficient, the decrease in distance 
vision was not tolerated, or there was a lack of intermediate visual performance.  A 
hybrid method combining micro-monovision and multifocal ablation could potentially 
achieve full range of vision. 
Long term follow-ups after Presbyopic corrections are scarce in the literature, 
although they are essential to understand the effects and implications of increasing 
presbyopia with age as a negative impact on outcomes for presbyopia surgery.  Further 
to that, so far it remains unknown whether the induced aberrations in 
multifocal/hyperprolate/aspheric ablations remain stable in the cornea in the long term. 
In this work, an already established cohort of patients treated with a hybrid bi-
aspheric micro-monovision technique10 are followed-up for 6 years and the outcomes 




This cohort study was based on a consecutive case series of patients treated by a 
single surgeon (MHAL), with a hybrid bi-aspheric micro-monovision technique to correct 
presbyopia, at Bergman Oogzorg / VisionClinics, Utrecht, the Netherlands.10 Signed 
informed consent was obtained from each patient, for both the treatment and use of 
their de-identified clinical data for publication. The Independent Review Board Nijmegen 
(IRBN) evaluated the study and stated that the investigation in this form is not subject to 
Medical Research Involving Human Subjects Act (WMO). Of the original cohort, 38 eyes 
(19 patients) completed the 6-year follow-up and were included for analyses. A 
summary of the preoperative demographics is presented in Table 1. The details of the 
cohort have been reported previously in detail.10 
 
Table 1. Preoperative Demographics. 
 Mean StdDev min MAX 
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Age (years) 51 3 45 55 
SEQ (D) -1.01 2.56 -6.75 +2.00 
Cylinder (D) 0.55 0.50 0 2.25 
Avg. K-
Readings (D) 
42.8 1.5 39.5 45.4 
CDVA 20/16 3 20/20 20/13 




5.8 0.8 4.0 7.5 
Planned OZ 
(mm) 
6.6 0.3 6.0 7.0 
 
POSTOPERATIVE EVALUATION 
Patients were reviewed at 66±1 months postoperatively (range 63 to 68 months [6 
years]). The clinical follow-up at 1-year postoperatively has been reported previously.10 
The results presented in this work expand the clinical follow-up to 6 years, and 
compares them to the previous follow-up visits. The follow-up rates are presented in 
table 2. The 6-year (6Y) follow-up visit included measurements of monocular and 
binocular Uncorrected Distance Visual Acuity (UDVA), Uncorrected Near Visual Acuity 
(UNVA), Uncorrected Intermediate Visual Acuity (UIVA), manifest refraction, Corrected 
Distance Visual Acuity (CDVA), Distance Corrected Near Visual Acuity (DCNVA), 
Distance Corrected Intermediate Visual Acuity (DCIVA) and defocus curves. The 
response to the Quality of Vision and Near Activity Visual Questionnaires, topography 
and aberrometry, were also recorded. A full ophthalmologic examination was performed 
on all the patients. CDVA and UDVA were evaluated using the Early Treatment Diabetic 
Retinopathy Study (ETDRS) charts. Near and intermediate acuity were assessed both 
unaided and distance corrected (UNVA, DCNVA, UIVA and DCIVA), with the Dutch 
version of the Radner Reading Charts at 40cm and 80cm, respectively. All tests were 
conducted monocularly and binocularly. 
 
Table 2. Follow-up rates. 
 Preoperative 6-week 3-month 6-month 1-year 6-year 
Patients 
(n) 
32 30 30 27 28 19 
Eyes (n) 64 60 60 54 56 38 
Follow-up 
rate (%) 
100% 94% 94% 84% 88% 59% 
 
The corrected visual acuity was always assessed with a phoropter. Binocular 
defocus curves were measured (with both eyes corrected for distance, i.e. eliminating 
the effect of the micro-monovision component) with induced lens blur from +1.5D to -
4.0D in 0.5D randomized spherical steps, using distance ETDRS charts with the letters 
randomized between presentations and magnification effects being accounted for.11 
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Corneal and ocular aberrometry was performed with the OPD-Scan II (Nidek, 
Gamagori, Japan) over a 6mm diameter. Root mean square (RMS) higher order 
aberrations, Strehl ratio and corneal asphericity were extracted.  
Subjective, patient reported outcomes were assessed using two questionnaires: 
the Quality of Vision questionnaire and the Near Activity Visual Questionnaire. The 
Quality of Vision questionnaire was developed by McAlinden et al.12 to assess 
symptoms such as glare, halos, starbursts etc. with the use of simulation photographs. 
Symptoms are scored based on scales of symptom frequency, severity and 
bothersomeness. The questionnaire is valid for use with spectacle wearers, contact lens 
wearers, patients who have undergone laser refractive surgery, intraocular refractive 
surgery, or having eye disease including cataract.13,14,15 The Near Activity Visual 
Questionnaire was used to assess patient satisfaction with near functional vision.16 The 
questionnaire has been validated for use with spectacles, contact lenses and intraocular 
refractive surgery.  Patients were instructed to answer the questionnaires to account 




Data were assessed for normality using the Shapiro-Wilk test. Analysis of variance and 
t-tests were performed on normally distributed data and Friedman tests and post-hoc 
Wilcoxon signed-ranks tests when the data was not normally distributed. Distance visual 
acuity was measured in logMAR but converted to equivalent Snellen fractions for 
reporting comparability. Similarly, near visual acuity was evaluated in logRAD but 
converted to Jaeger scale for reporting comparability. 
 
RESULTS 
Standard graphs for Reporting Astigmatism Outcomes of Refractive Surgery 
At 6Y binocularly, 53% of the patients reached an UDVA of 20/16 or better (Fig 1A), for 
95% of the patients UDVA remained within one line of preoperative CDVA (Fig 1B), no 
patient lost lines of CDVA (although 16% of the NE lost 2 lines of CDVA) (Fig 1C).  At 
6Y binocularly, 68% of the patients reached an UNVA of J2 or better (Fig 1D), for 47% 
of the patients UNVA remained within one line of preoperative CNVA (Fig 1E), no 
patient lost 2 lines of CNVA (although 21% of the DE and 11% of the NE lost 2 lines of 
CDVA) (Fig 1F). 
At 6Y, the scattergram showed some 10% undercorrection in SEQ with 1D separation 
between DE and NE (Fig 1G), 74% of DE were within 0.5D from emmetropia and 58% 
of NE were within 0.5D from -0.9D target (Fig 1H), 89% and 74% of the eyes were 












At 6Y, the mean monocular UDVA was 20/20±5 letters DE, 20/43±12 letters for NE, and 
20/18±4 letters binocularly (Fig 2A).  At 6Y, the mean UIVA was J3.2 for DE, J1.0 for 
NE, and J1.0 binocularly (Fig 2B).  At 6Y, the mean UNVA was J8.5 for DE; J2.1 for NE; 





Fig. 2. EFFICACY: Mean uncorrected visual acuity up to 6-years follow up after treating 
with Hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal 





Good refractive separation was observed between the DE and NE, for spherical 
equivalent and astigmatic error (figure 3). Spherical equivalent showed a +0.1D per 
year increase (hyperopic drift) (p=0.002) for DE and NE (Fig 3A). Refractive 




Fig. 3. ACCURACY: Mean manifest refraction assessed preoperatively, and up to 6 
years follow up after treating with Hybrid bi-aspheric micro-monovision ablation profile 





At 6Y, mean CDVA was 20/15±3 letters for DE; 20/19±5 letters for NE; and 20/14±3 
letters binocularly (Fig 4A).  At 6Y, the mean CIVA was J1.0 for DE; J1.0 for NE; and 
J1.0 binocularly (Fig 4B).  At 6Y, the mean CNVA was J2.2 for DE; J1.5 for NE; and 





Fig. 4. SAFETY: Mean corrected visual acuity up to 6-years follow up after treating with 
Hybrid bi-aspheric micro-monovision ablation profile for presbyopic corneal treatments. 





At 6Y, the mean DCIVA was J2.5 for DE; J1.8 for NE; and J1.1 binocularly (Fig 5A).  At 




Fig. 5. PSEUDOACCOMMODATION: Mean distance corrected visual acuity up to 6-
years follow up after treating with Hybrid bi-aspheric micro-monovision ablation profile 





Binocular defocus curves (preoperatively and at 1 and 6 years follow-up) are presented 
in figure 6. The difference in defocus curves shows an improvement of 0.4 Snellen lines 
at best focus from 1Y to 6Y follow-up (p=0.008), reaching preoperative levels (p=0.5). 
 
 
Fig. 6. DEFOCUS CURVES: Binocular defocus curves from uncorrected vision 
asymmetrically to longer (+1.5D) and shorter vergences (-4.0D), assessed 
preoperatively and at one and six years follow up after treating with Hybrid bi-aspheric 
micro-monovision ablation profile for presbyopic corneal treatments. The error bars 




Asphericity was more prolate after surgery indicating central myopia (within a 3mm 
diameter, p=0.0003 for OPD-Scan II but not for Pentacam, p=0.4).  Throughout the 
follow-up, asphericity became less prolate (0.03 units per year, p=0.01 for OPD-Scan II 
but not for Pentacam, p=0.1) (Fig 7A).  Compared to the preoperative status, the 
corneal and ocular spherical aberrations (at ~5.4 mm diameter, Fig 7B) decreased 
(p=0.0005) and were stable from 3M follow-up (p=0.1) (Fig 7C), with an increase in 
RMS higher order aberrations (at a 6 mm diameter) (p=0.05) stable from 3M follow-up 






Fig. 7. ABERRATIONS: Corneal asphericity (Q value) at 3mm diameter, Root mean 
square (RMS) of higher order aberrations (at 6mm diameter), corneal and ocular 
spherical aberrations (Corn SA and OC SA respectively, at 6mm diameter) 
preoperatively, and up to six years follow up after treating with Hybrid bi-aspheric micro-
monovision ablation profile for presbyopic corneal treatments. Top Left) Corneal 
asphericity Top Right) Analysis diameter for ocular aberrations Bottom Left) Spherical 




Compared to the corrected preoperative scores, the Quality of Vision at 6Y was 
comparable to preoperative for all questionnaire items (p=0.1), but improved from 1Y 
scores mainly with a reduction in reported haloes (p=0.01) and blurred vision (p=0.03) 
(Table 3). Composite Rasch-scaled scores are displayed in Fig. 8 (Top).  Scores 
continue to improve up to 6Y, returning to preoperative levels. 
Compared to the preoperatively, at 6 Y follow up, The Near Activity Visual 
Questionnaire scores improved from little to high satisfaction level for all items 
(p=0.002), however, the scores for reading small print, medicine and food packaging, 
bank statements, writing letters, and conducting near work worsened from 1Y 
postoperatively to 6Y follow up (p=0.04) (Table 4).  Overall scores are displayed in Fig. 
8 (Bottom).  Scores worsened between 1Y and 6Y, but symptoms remained well below 






Fig. 8. SUBJECTIVE RATING: Patient Reported Outcomes assessed preoperatively, 
and up to 6 years follow up after treating with Hybrid bi-aspheric micro-monovision 







Table 3. QoV Questionnaire. 
QoV Item Frequency Severity Bothersome 



















1 Glare 0.5±0.7 0.7±0.8 0.5±0.6 0.1 0.3 0.5±0.7 0.9±0.9 0.7±0.9 0.4 0.4 0.5±0.7 0.7±0.8 0.6±0.7 0.4 0.4 
2 Haloes 0.3±0.4 1.0±0.7 0.3±0.5 0.4 0.005 0.3±0.5 1.1±0.9 0.4±0.7 0.5 0.01 0.3±0.4 0.9±1.0 0.3±0.4 0.4 0.004 
3 Starburst 0.5±0.7 0.6±0.7 0.4±0.6 0.3 0.5 0.5±0.7 0.6±0.7 0.4±0.6 0.2 0.3 0.4±0.5 0.4±0.9 0.2±0.4 0.1 0.4 
4 Hazy Vision 0.2±0.4 0.4±0.6 0.1±0.3 0.1 0.1 0.2±0.4 0.4±0.7 0.2±0.4 0.2 0.2 0.2±0.4 0.4±0.7 0.1±0.3 0.1 0.1 
5 Blurred 
Vision 
0.6±0.7 1.3±1.0 0.6±0.5 0.4 0.1 0.6±0.7 1.4±1.1 0.6±0.5 0.4 0.08 0.5±0.7 1.3±1.1 0.4±0.5 0.2 0.03 
6 Distortion 0.1±0.2 0.1±0.3 0.1±0.2 0.2 0.2 0.1±0.2 0.1±0.3 0.1±0.2 0.2 0.2 0.1±0.2 0.1±0.3 0.1±0.2 0.2 0.2 
7 Multiple 
Images 
0.1±0.2 0.5±0.8 0.1±0.2 0.5 0.05 0.1±0.2 0.5±0.8 0.1±0.2 0.5 0.05 0.1±0.2 0.5±0.8 0.1±0.2 0.5 0.05 
8 Fluctuations 0.5±0.6 0.9±0.7 0.6±0.6 0.4 0.4 0.6±0.8 1.0±0.8 0.6±0.6 0.2 0.2 0.6±0.8 0.9±0.8 0.5±0.6 0.1 0.2 
9 Focusing 
Difficulties 
0.9±0.6 1.3±0.7 1.0±0.0 0.2 0.3 0.9±0.6 1.2±0.7 1.0±0.3 0.2 0.2 0.9±0.6 1.1±0.9 0.9±0.4 0.1 0.4 
10 Depth 
Perception 
0.4±0.5 0.5±0.6 0.5±0.6 0.4 0.4 0.3±0.5 0.5±0.6 0.5±0.7 0.4 0.3 0.4±0.6 0.5±0.6 0.5±0.6 0.4 0.4 
 Rasch 
Score 
33±5 47±6 36±4 0.3 0.1 28±5 41±5 31±4 0.3 0.05 30±5 42±7 29±5 0.1 0.1 
 
Table 4. NAVQ Questionnaire. 





1 Reading small print, such as 
newspaper articles, items on a 
menu, telephone directories? 
1.9±1.0 0.3±0.5 0.7±0.8 0.0003 0.01 
2 Reading 
labels/instructions/ingredients/prices, 
such as on medicine bottles, food 
packaging? 
2.2±1.0 0.4±0.5 1.1±0.9 0.002 0.002 
3 Reading your post/mail, such as 
electric bills, greeting cards, bank 
statements, letters from friends and 
family? 
1.9±1.1 0.1±0.3 0.4±0.6 0.0000009 0.03 
4 Writing and reading your own 
writing, such as greeting cards, 
notes, letters, filling in forms, checks, 
signing your name? 
1.6±1.0 0.0±0.0 0.2±0.4 0.0000002 0.02 
5 Seeing the display and keyboard on 
a computer or calculator? 
1.8±0.9 0.3±0.5 0.4±0.6 0.00008 0.09 
6 Seeing the display and keyboard on 
a mobile or fixed telephone? 
2.0±1.0 0.2±0.4 0.6±0.7 0.00009 0.06 
7 Seeing objects close to you and 
engaging in your hobbies, such as 
1.6±0.9 0.0±0.2 0.2±0.4 0.000000005 0.08 
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playing card games, gardening, 
seeing photographs? 
8 Seeing objects close to you in poor 
or dim light? 
1.8±0.9 0.6±0.6 0.8±0.8 0.00006 0.08 
9 Maintaining focus for prolonged near 
work? 
1.5±0.9 0.4±0.6 0.6±0.7 0.0001 0.3 
10 Conducting near work without 
spectacles? 
1.8±1.1 0.2±0.4 0.6±0.9 0.0002 0.04 
11 Overall Score 3.3±0.3 1.1±0.3 1.7±0.5 0.0002 0.05 




Secondary treatment was performed in 3 eyes (3 patients: 8% from the 38 eyes, but 
16% of the patients) to improve distance outcomes. The secondary treatments were 
performed using a non-wavefront guided aspheric treatment to alter the distance 
refraction to the desired value. One of them (3% from the 38 eyes, but 5% of the 
patients) was combined with a partial presby reversal treatment to reduce the effects of 
the primary treatment, due to the patient’s perceived intolerance (mainly loss of CDVA) 
to the induced multifocality. The details about the reversal of this technique and 
corresponding aberrations and topography changes have been published elsewhere.17  
All retreatments were performed between 6-months and 1-year after the initial 
treatment.  No further retreatments were performed after 1Y postop, and no retreated 
eyes required a further retreatment. 
 
DISCUSSION 
This case series analyzed the long term longitudinal changes up to 6Y follow-up of the 
efficacy and safety of presbyopic treatment using a hybrid bi-aspheric micro-monovision 
ablation profile. This technique aims to combine the benefits of multifocal ablations and 
micro-monovision with enhanced depth of focus and a wider range of intermediate 
vision. The analysis revealed very stable long-term results after the treatment. The 
binocular vision was expected to improve overall, with NE imparting an improvement in 
NAVQ scores and the DE imparting an improvement in QoV scores. Most of the 
outcome measures showed significant improvement compared to the preoperative 
status. The improvement in visual acuities was significant. In addition, analyzing the 
NAVQ responses revealed an improvement in all the topics from little (pre-operative) to 
high (post-operative) satisfaction.  Although, it would be interesting to know the profile of 
the defocus curves monocularly for the presbyopic eyes; this was not part of the study 
protocol. However, the defocus curves with both eyes corrected for distance, i.e. 
eliminating the effect of the micro-monovision component, revealed an improvement of 
half a Snellen line at the best focus for distance compared to 1Y follow-up, reaching 
preoperative levels, but an overall loss compared to 1Y at near vergences. Monocularly, 
it would be expected that the defocus curves would be shallower, with refractive 
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separation between the dominant and non-dominant eye. Defocus curves were 
assessed with trial lenses additive to the distance refraction while observing the ETDRS 
distance charts. This means that the naturally occurring pupil miosis (enhancing depth 
of focus) has been eliminated from the measurements, and actual reading and 
intermediate acuities may actually be better than those obtained in the defocus curves. 
As often found in long-term follow-up studies, the number of patients attending 
the different follow-ups was not constant, the analyses performed was both based on a 
paired comparison (i.e. only the subset patients attending all follow-ups) as well as 
unpaired comparisons (i.e. comparing the mean and standard errors for the different 
follow-ups).  Both analyses revealed the same trends. The main concern, however, 
remains in the relatively high loss to follow-up of 41% from preoperative, or 32% from 1-
year follow-up baseline.  The potential impact of this loss to follow-up is difficult to be 
assessed.  Clearly, this reduced follow-up rate decreases the statistical power of the 
analyses, i.e. the probability of making a type II error (wrongly failing to reject the null 
hypothesis) increases. 
UDVA was stable for DE (from 6W postoperatively) and binocularly (from 6M 
postoperatively) and continued to improve for NE through the years. Whereas for UIVA 
there was a worsening effect with time for DE, with an improvement for NE and 
binocular through the years observed. For UNVA, there was a global loss of 
effectiveness through the years.  This corresponds well with the progression of MRSE 
with time moving from -0.17±0.37D at 1Y to +0.32±0.51D at 6Y for DE, and from -
1.35±0.56D at 1Y to -0.86±0.56D at 6Y for NE.  Refractive astigmatism was stable from 
6W follow-up. Also the additional help of true accommodation will decrease over time. 
A good separation in the refractive outcome was observed between the DE and 
NE, for spherical equivalent corresponding to the planned micro-monovision.  DE drove 
binocular UDVA, and NE binocular UNVA.  For UIVA, DE and NE crossed over at 
around 2Y postop but binocular UIVA remained stable.  This cross-over was due to the 
slow drift in refraction observed for both DE and NE.  Until 1Y follow-up, DE (slightly 
myopic and with moderate depth of focus) drove binocular UIVA (NE was more myopic 
with larger depth of focus), whereas at 6Y DE (slightly hyperopic and with moderate 
depth of focus) could no longer drive binocular UIVA, but NE (less myopic than at 1Y 
with larger depth of focus) covered better the intermediate region. 
CDVA continued to improve during the 6Y follow-up reaching preoperative levels, 
whereas CIVA and CNVA reached preoperative levels at 6M follow-up and remained 
stable thereafter. Corrected VA was normal for DE and NE at all distances and follow-
up times.  DE drove binocular (C)DVA and (C)IVA (likely due to the hybrid approach, 
inducing half of the spherical aberration (SphAb) in DE, i.e. inducing less detrimental 
effects in distance and intermediate visions), and NE binocular (C)NVA. 
Pseudoaccommodation, measured as IVA and NVA with distance correction, 
reached at least preoperative levels and remained stable from 6W postop, except for 
DCNVA in DE (at 6Y worse than preoperative, and decreased 0.2 lines per year).  NE 
drove binocular DCIVA and DCNVA (likely due to the hybrid approach, inducing twice 
as much SphAb in NE, i.e. inducing higher gains in intermediate and near visions). 
Asphericity was more prolate when measured with the OPD-Scan II than the 
values measured with the Pentacam.  Postoperative asphericities were more prolate 
than preoperatively (indicating central myopia), with NE showing systematically more 
negative asphericities at all postoperative times, and a slight trend of losing 
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hyperprolateness with time only measured by the OPD-Scan II (but not with the 
Pentacam, and also not confirmed by the SphAb).  
Aberrations were induced across a 6mm corneal diameter, but ocular aberrations 
could only be measured through the pupil so that the actual values of analysis diameter 
were in the range of 5.4±0.2mm (stable throughout time). SphAb was more negative 
when measured with ocular aberrations than for corneal aberrations.  Postoperative 
SphAb was more negative than preoperative (indicating central myopia), with NE 
showing systematically more negative values at all postoperative times (both for corneal 
and ocular SphAb), remaining (apparently) stable from 3M follow-up.  The RMS higher 
order aberrations increased, with NE showing systematically higher inductions HOA at 
all postoperative follow-ups.  Both the induction of SphAb (corneal or ocular, for DE or 
NE), as well as the postoperative ocular SphAb for NE were within -0.6µm. This level 
has been reported previously as the maximum compromise between the gain in near 
visual acuity versus the loss in distance visual acuity,18 although newer assessments 
have suggested that with a 0.2µm induction, there is a just noticeable impact in 
perceived image quality.19 
Binocular defocus curve at 6Y of follow-up seems to lie between the preoperative 
and 1Y postoperative defocus curves. Actually, it seems that there was a (not 
significant) loss of VA for shorter vergences compared to 1Y follow-up, despite the fact 
that SphAb (and HOA) was largely stable from 3M follow-up.  This may indicate that for 
the long term, the micro-monovision component is more relevant in influencing the near 
visual performance of the patient than the induction of HOAs. Defocus curves contradict 
this: wider curves indicate pseudoaccommodation which must be a HOA effect. So 
decrease in near vision must be due to decrease in true accommodation. 
QoV scores at 6Y were comparable to preoperative scores for all questionnaire 
items, and the previously reported haloes and blurred vision symptoms at 1Y resolved 
at 6Y. NAVQ scores assessing patient satisfaction with near functional vision improved 
for all items from preoperative, but the scores for reading small print, medicine and food 
packaging, bank statements, writing letters, and conducting near work worsened from 
1Y postoperative (confirming the UNVA and defocus curve findings).  There may be 
potential adjustments in the surgical goals or some other approach to remedy this 
complication.  Surgeons may decide to increase the monovision effect (-0.9D in this 
work) to -1.25D or -1.5D to further strengthen NVA; alternative options could be to 
increase the depth of focus (+2.2D for NE in this work) to +2.5D or +2.75D (at the 
expense of a longer adaptation time for the recovery of UDVA).  Both alternatives could 
be equally combined with near vision training. 
Leydolt et al.20 showed that near vision training made patients more independent 
of reading glasses. This was made by comparing a “motivated” group (instructed not to 
use reading glasses for at least three months) to a “control” group.  On questioning the 
patients with a questionnaire, which was also done in an observer-masked fashion, it 
was found that the motivated group reported significantly better scores for near vision 
tasks without glasses. Additionally, the motivated group had a proportion of 40% 
(8patients) that never used glasses at the one year interview compared with none in the 
control group.  Authors concluded that either impeding the use of reading glasses in the 
first months after surgery or motivation enhances near visual performance and results in 
a higher degree of spectacle independence.  Therefore, studies that examine 
presbyopia treating strategies, such as accommodating IOLs, corneal presbyopic 
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ablations, or multifocal IOLs, should not underestimate this ‘placebo’ effect of patient 
motivation that is present all the time.  Whether this effect holds for longer terms (6 
years in our cohort) remains unclear.  But this may be reinforced with training 
strategies.4  
All retreatments performed between 6-months and 1-year follow-ups after the 
initial treatment were reported previously.10 One late retreatment was bilaterally 
performed after 6Y postop (hyperopic PRK in both eyes of 1 patient, NE was 
emmetropic, DE was hyperopic), but no retreated eyes required a second retreatment.  
Many clinical studies have evaluated various surgical techniques to treat 
presbyopia; however the current developments throughout the corneal presbyopic 
correction spectrum indicate a converging trend towards hybrid techniques. These 
hybrid modifications include: SupracorTM (TECHNOLAS Perfect Vision GmbH),21 
PresbyMAX (reduced multifocality in the distance eye combined with full multifocality 
and monovision in the near eye),10 Intracor (full correction in the distance eye combined 
with multifocality and monovision in the near eye),22 KAMRATM (AcuFocus, Inc.) (full 
correction in the distance eye combined with pinhole based extended depth-of-focus 
and monovision in the near eye),23 PresbyondTM (Carl Zeiss Meditec AG) (laser blended 
vision (moderate multifocality in both eyes combined with monovision in the near 
eye)),24 and refractive corneal inlays (e.g. RaindropTM from ReVision Optics, USA; now 
withdrawn from the market).25 
Methods depending only on the depth of focus might face difficulty to create more 
than 1.5D of range of focus, providing spectacle independence. In contrast, models 
combining µ-monovision with depth of focus may provide a higher near vision 
independence. Since, presbyopia increases with age, a wide range of near vision shall 
be an asset in such cases. In addition, the difference in the depth of focus between the 
near and far eye provides the patient with a wider binocular range of focus for an 
enhanced intermediate vision.  
Corneal topography and aberrometery revealed an induction of negative SphAb 
in corneal and ocular spherical aberrations, associated with an increase in the RMS 
higher order aberrations. Furthermore, QoV responses revealed a recovery to 
preoperative (using correction glasses) levels for all items, including improvement in 
terms of haloes and blurred vision post-operatively compared to the patient responses 
at 1Y follow-up. The presented clinical outcomes are based on 6 years of clinical follow-
up, which is considered long-term in refractive surgery. However, presbyopia increases 
with age. Therefore, even longer follow-ups could shed light on the durability of 
performance during further degradation of accommodation. 
Other techniques reported long-term outcomes, but all shorter than 6Y.  This 
includes intrastromal femtosecond laser presbyopia (3-years, showing a refractive 
progression of 0.13D per year),22 intracorneal pinhole inlays (5-years),23,26 or conductive 
keratoplasty (3-years, showing a refractive progression of 0.13D per year),27.  From our 
cohort, as well as previous reports for other techniques, it seems that 0.13D per year is 
a reasonable estimate of the presbyopic progression at the considered ages (in our 
case ~51 year old at the time of treatment).  Further, it seems that this presbyopic 
progression is not truly a corneal regression, but lenticular changes (corneal curvature 
did not change postoperatively in our cohort, as well as with conductive keratoplasty27). 
The depth of focus acts as a useful marker, however, some studies consider 
acuity at a typical near vision distance as a more suitable metric that is closely related to 
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patient expectations and concerns.28 Our analysis and results indicate significant 
success in presbyopic treatments using the hybrid bi-aspheric micro-monovision 
ablation profiles. Presbyopic treatment using a hybrid bi-aspheric micro-monovision 
ablation profile is safe and efficacious. The post-operative outcomes indicate 
improvements in binocular vision at far, intermediate and near distances with improved 
contrast sensitivity. An 8% retreatment rate should be considered to increase 
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